Radiation Therapy and Concurrent Cisplatin in Management of Locoregionally Advanced Nasopharyngeal Carcinomas
Authors:
- H S ErkalHEH S Erkal
- A CakmakACA Cakmak
Open Access
- 1 January 1999
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 38 (8) , 1031-1035
Abstract
Radiation therapy in combination with chemotherapy in the management of locoregionally advanced nasopharyngeal carcinomas is evaluated in an attempt to improve locoregional response, reduce locoregional failure and reduce systemic failure. The current study was designed to investigate radiation therapy and concurrent cisplatin in this context. From 1992 through 1997, 70 patients with locoregionally advanced nasopharyngeal carcinomas were treated with radiation therapy and concurrent cisplatin. External beam radiation dose was 60 Gy for T1, T2 and T3 tumors, 70 Gy for T4 tumors and 70 Gy for metastatic cervical lymph nodes. An intracavitary brachytherapy boost (10 Gy) was applied for T1, T2 and T3 tumors. Cisplatin (30 mg/m2) was administered weekly during external beam radiation therapy. Locoregional complete response was achieved in 63 patients, locoregional failure was observed in 4 patients and systemic failure was observed in 15. N-stage predicted systemic failure. Overall survival, locoregional failure-free survival and systemic failure-free survival were 63%, 79% and 75%, respectively, at three years. Grade 3 acute skin toxicity was observed in 2 patients, Grade 3 acute mucous membrane toxicity was observed in 6 and Grade 3 acute hematological toxicity was observed in 2 patients. Despite improved locoregional response, reduced locoregional failure and improved survival with radiation therapy and concurrent cisplatin, systemic failure remains prevalent for locoregionally advanced nasopharyngeal carcinomas.Keywords
This publication has 22 references indexed in Scilit:
- Carcinoma of the nasopharynx treated by radiotherapy alone: Determinants of local and regional controlInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Effect of time, dose and fractionation on local control of nasopharyngeal carcinomaRadiotherapy and Oncology, 1995
- Concurrent cisplatinum and radiation for advanced head and neck cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995
- Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
- Improved dose distributions for 3d conformal boost treatments in carcinoma of the nasopharynxInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1991
- Prognostic factors of nasopharyngeal carcinoma: a review of 759 patientsBritish Journal of Radiology, 1990
- Combined treatment in carcinoma of the nasopharynxThe Laryngoscope, 1988
- Nasopharyngeal carcinoma: Result of treatment with cis-diamminedichloroplatinum II, 5 fluorouracil, and radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1988
- Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical dataInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1987